Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT01660568 |
Date of registration:
|
06/08/2012 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Gemcitabine in NK/T Cell Lymphoma
|
Scientific title:
|
Gemcitabine in Pretreated/Refractory NK/T Cell Lymphoma |
Date of first enrolment:
|
August 2012 |
Target sample size:
|
20 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT01660568 |
Study type:
|
Observational |
Study design:
|
Observational Model: Cohort, Time Perspective: Retrospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Korea, Republic of
| | | | | | | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- NK/T cell lymphoma
- relapse or refractory disease
- gemcitabine containing treatment
Exclusion Criteria:
Age minimum:
15 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
NK/T Cell Lymphoma
|
Primary Outcome(s)
|
Overall response rate
[Time Frame: 2012-May]
|
Secondary ID(s)
|
2012-07-043
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|